|
Name |
Prenylterphenyllin
|
Molecular Formula | C25H26O5 | |
IUPAC Name* |
2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-5-(4-hydroxyphenyl)-3,6-dimethoxyphenol
|
|
SMILES |
CC(=CCC1=C(C=CC(=C1)C2=C(C=C(C(=C2O)OC)C3=CC=C(C=C3)O)OC)O)C
|
|
InChI |
InChI=1S/C25H26O5/c1-15(2)5-6-17-13-18(9-12-21(17)27)23-22(29-3)14-20(25(30-4)24(23)28)16-7-10-19(26)11-8-16/h5,7-14,26-28H,6H2,1-4H3
|
|
InChIKey |
YEVBMDOXFLFVJJ-UHFFFAOYSA-N
|
|
Synonyms |
PRENYLTERPHENYLLIN; CHEBI:67533; Prenyltherphenyllin; CHEMBL1795464; DTXSID601315915; BDBM50457902; Q27136002; 2-[4-hydroxy-3-(3-methylbut-2-enyl)phenyl]-5-(4-hydroxyphenyl)-3,6-dimethoxyphenol; 3',6'-dimethoxy-3-(3-methylbut-2-en-1-yl)-1,1':4',1''-terphenyl-2',4,4''-triol; 959124-85-7
|
|
CAS | 959124-85-7 | |
PubChem CID | 23630784 | |
ChEMBL ID | CHEMBL1795464 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 406.5 | ALogp: | 6.0 |
HBD: | 3 | HBA: | 5 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 79.2 | Aromatic Rings: | 3 |
Heavy Atoms: | 30 | QED Weighted: | 0.45 |
Caco-2 Permeability: | -4.857 | MDCK Permeability: | 0.00001270 |
Pgp-inhibitor: | 0.336 | Pgp-substrate: | 0.013 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.826 |
30% Bioavailability (F30%): | 0.199 |
Blood-Brain-Barrier Penetration (BBB): | 0.006 | Plasma Protein Binding (PPB): | 98.95% |
Volume Distribution (VD): | 0.743 | Fu: | 1.40% |
CYP1A2-inhibitor: | 0.848 | CYP1A2-substrate: | 0.727 |
CYP2C19-inhibitor: | 0.957 | CYP2C19-substrate: | 0.065 |
CYP2C9-inhibitor: | 0.847 | CYP2C9-substrate: | 0.942 |
CYP2D6-inhibitor: | 0.694 | CYP2D6-substrate: | 0.918 |
CYP3A4-inhibitor: | 0.448 | CYP3A4-substrate: | 0.377 |
Clearance (CL): | 9.529 | Half-life (T1/2): | 0.496 |
hERG Blockers: | 0.085 | Human Hepatotoxicity (H-HT): | 0.135 |
Drug-inuced Liver Injury (DILI): | 0.753 | AMES Toxicity: | 0.064 |
Rat Oral Acute Toxicity: | 0.083 | Maximum Recommended Daily Dose: | 0.083 |
Skin Sensitization: | 0.65 | Carcinogencity: | 0.045 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.572 |
Respiratory Toxicity: | 0.199 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002776 | 0.953 | D06GCK | 0.357 | ||||
ENC005867 | 0.837 | D0Q9ON | 0.333 | ||||
ENC005868 | 0.837 | D0Q0PR | 0.329 | ||||
ENC002758 | 0.787 | D0J7RK | 0.295 | ||||
ENC002453 | 0.783 | D0AZ8C | 0.293 | ||||
ENC005039 | 0.742 | D07MGA | 0.286 | ||||
ENC002011 | 0.720 | D06FOU | 0.279 | ||||
ENC000826 | 0.663 | D0K8KX | 0.277 | ||||
ENC005870 | 0.625 | D06KYN | 0.276 | ||||
ENC005871 | 0.625 | D09ZQN | 0.275 |